Immuron Ltd (IMC.AX) Quote| Reuters.com
Edition:
United States

Immuron Ltd (IMC.AX)

IMC.AX on Australia Stock Exchange

0.25AUD
24 Jun 2016
Change (% chg)

$-0.01 (-5.56%)
Prev Close
$0.27
Open
$0.26
Day's High
$0.26
Day's Low
$0.25
Volume
27,300
Avg. Vol
49,936
52-wk High
$0.57
52-wk Low
$0.22

IMC.AX

Chart for IMC.AX

About

Immuron Limited is an Australia-based product development driven biopharmaceutical company. The Company is focused on the research and development of polyclonal antibodies for the treatment and prevention of a range of infectious and immune modulated diseases. The Company operates through three segments: Research and Development... (more)
No analyst recommendations are available for IMC.AX.

Overall

Beta: -0.69
Market Cap(Mil.): $26.55
Shares Outstanding(Mil.): 104.13
Dividend: --
Yield (%): --

Financials

  IMC.AX Industry Sector
P/E (TTM): -- 32.69 34.11
EPS (TTM): -0.05 -- --
ROI: -109.20 15.00 14.23
ROE: -109.20 16.08 15.46

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Sadif Analytics Prime
$10.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.